Concepedia

Author

Christoph Meisner

University of TübingenORCID

Also Known As

C Meisner, C. Meisner, Christoph Meisner, Denise Wrobel, Dirk-Michael Zahm, Ilka Bernhöft, Imma Fischer

94

Publications

3.5K

Citations

27

H-Index

60

Concepts

All Affiliations

University of TübingenUniversity Children's Hospital TübingenRobert Bosch HospitalGoethe University FrankfurtZimmer Biomet (Germany)
CM

About

Christoph Meisner is an author at University of Tübingen specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

685

2

Health Sciences

4

4

222

3

Arts

1

1

24

4

Public Health

1

1

15

5

Biostatistics

1

1

57

Christoph Meisner

×

34

Publications

2.9K

Citations

24

H-Index

YearCitations

Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

F. Jänicke, A. Prechtl, Christoph Thomssen,

JNCI Journal of the National Cancer Institute

2001

437

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler,

Nature

2021

268

Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial

Margarete Teresa Walach, Christoph Meisner, Melanie Fritz,

Brain

2013

210

A double-blind randomized placebo-controlled phase III study of a <i>Pseudomonas aeruginosa</i> flagella vaccine in cystic fibrosis patients

Gerd Döring, Christoph Meisner, Martin Stern

Proceedings of the National Academy of Sciences

2007

187

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Nadia Harbeck, Manfred Schmitt, Christoph Meisner,

European Journal of Cancer

2013

163

First-Line High-Dose Chemotherapy Compared With Standard-Dose PEB/VIP Chemotherapy in Patients With Advanced Germ Cell Tumors: A Multivariate and Matched-Pair Analysis

Carsten Bokemeyer, Christian Kollmannsberger, Christoph Meisner,

Journal of Clinical Oncology

1999

162

Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy

Stefan K. Plontke, Hubert Löwenheim, Jürgen Mertens,

The Laryngoscope

2009

161

Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis

Alexandra Heininger, Helene A. Haeberle, Imma Fischer,

Critical Care

2011

160

Determinants of Life Satisfaction in Inflammatory Bowel Disease

Karl-Heinz Janke, Bodo Klump, Michael Gregor,

Inflammatory Bowel Diseases

2005

140

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)

Karl R. Karsch, Melitta B. Preisack, R. Baildon,

Journal of the American College of Cardiology

1996

122

Page 1